Where Does China Pharma Holdings Inc. (CPHI) Rank When It Comes To Price-To-Earnings Ratio?

China Pharma Holdings Inc. (AMEX:CPHI) finished Friday with an addition of $0.02 to close at $0.58, an upside of 3.50 percent. An average of 435,300 shares of common stock have been traded in the last five days. There was a gain of $0.0263 in the past week, and it reached a new high 11 times over the past 12 months. The last 20 days have seen an average of 331,625 shares traded, while the 50-day average volume stands at 336,634.

CPHI stock has decreased by -3.95% in the last month. The company shares reached their 1-month lowest point of $0.5000 on 10/06/21. With the stock rallying to its 52-week high on 03/29/21, shares of the company touched a low of $0.37 and a high of $1.63 in 52 weeks. It has reached a new high 11 times so far this year and achieved 29.27% or $0.1305 in price. In spite of this, the price is down -64.64% from the 52-week high.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Valuation Metrics

China Pharma Holdings Inc. (CPHI) has a trailing price-to-earnings (P/E) ratio of 23.00 for the broader industry and 33.43 for the sector. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 2.19, the price-to-book (PB) ratio at 3.67.

China Pharma Holdings Inc.’s EBITDA margin for the year ending September 29 is 0.93%. Its gross profit as reported stood at $1.95 million compared to revenue of $10.87 million.

Earnings Surprise

For the three-month period that ended September 29, China Pharma Holdings Inc. had $0.33 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$0.82 million in the quarter, while revenues were grew 101.22%. The analyst consensus anticipated China Pharma Holdings Inc.’s latest quarter earnings to come in at $0.12 per share, but it turned out to be $0.08, a -33.30% surprise. For the quarter, EBITDA amounted to $53000.0. Shareholders own equity worth $43.58 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at China Pharma Holdings Inc. (CPHI) price momentum. RSI 9-day as of the close on 22 October was 53.79%, suggesting the stock is Neutral, with historical volatility in this time frame at 44.52%.

As of today, CPHI’s price is $0.5681 +4.78% or $0.0263 from its 5-day moving average. CPHI is currently trading -0.72% lower than its 20-day SMA and -32.87% lower than its 100-day SMA. However, the stock’s current price level is -34.50% below the SMA50 and +5.74% above the SMA200.

The stochastic %K and %D were 46.37% and 48.28%, respectively, and the average true range (ATR) was 0.0493. With the 14-day stochastic at 51.73% and the average true range at 0.0472, the RSI (14) stands at 49.12%. The stock has reached 0.0093 on the 9-day MACD Oscillator while the 14-day reading was at 0.0144.

Analyst Ratings

Rodman & Renshaw launched coverage on China Pharma Holdings Inc. (AMEX: CPHI) in its analyst report released on January 08, 2010. The firm assigned the stock a a Mkt outperform rating. The consensus rating for China Pharma Holdings Inc. (CPHI) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CPHI, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.

What is CPHI’s price target for the next 12 months?

Analysts predict a range of price targets between $4.50 and $4.50, with a median target of $4.50. Taking a look at these predictions, the average price target given by analysts for China Pharma Holdings Inc. (CPHI) stock is $4.50.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Hot Topics

Related Videos

Related Videos

Related Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

592

100% free. stop anytime no spam